Work

The adverse reactions of bevacizumab in combination with the FOLFOX chemotherapy regimen in metastatic colorectal cancer

Year: 2025

Type: article

Study design: Observational Study

Source: Expert Opinion on Drug Safety

DOI: 10.1080/14740338.2025.2490274

Authors: DongQiang Luo, Jiyuan Zheng, Bingshuo Liu, Bohui Zheng, JiaZhen Jiang, Shulan Huang, Zilan Zhong, Wenling Zeng

Institutions: Guangzhou University of Chinese Medicine, Southern Medical University, Nanchang University

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409240206

FWCI: 1.368

Cites: 29

Cited by: 1

Related to: 10